NAUT Q4 2019 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$289M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$355,000

Net Income

$385,490

EPS (Diluted)

$0.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$88,992

Free Cash Flow

-$88,992

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$19M

Total Liabilities

$490,000

Stockholders' Equity

$18M

Cash & Equivalents

$595,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$355,000	-$112M	+99.7%
Net Income	$385,490	$627M	-99.9%